INVO BioScience (QB) Stock Price

0.00 (0.0%)
Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
INVO BioScience Inc (QB) IVOB OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.22 20:00:00
Low Price High Price Open Price Previous Close
0.00 0.00 0.00 0.22
Bid Price Ask Price Spread News
0.20 0.253 0.053 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.22 USD

INVO BioScience (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 34.71M 157.77M 50.56M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
5.97k $ - 0.00% - -

more financials information »

INVO BioScience (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IVOB Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months0.2558750.260.1130.23960944,989-0.03588-14.02%
1 Year0.32380.32510.1130.261985260,948-0.1038-32.06%
3 Years0.2350.770.080.357087352,175-0.015-6.38%
5 Years0.493.000.080.480414160,025-0.27-55.1%

INVO BioScience (QB) Description

INVO Bioscience, Inc. offers novel solutions in assisted reproductive technologies(ART)while expanding geographic and affordable access to the global reproductive health care community. Our primary focus is the manufacture and sale of the INVOcell device and the INVO technology to assist infertile couples in having a baby. We designed our INVOcell device and our INVO procedure to provide an alternative infertility treatment for the patient and the clinician. The INVO procedure is less expensive and simpler to perform than most comparable infertility treatments currently. The simplicity of the INVO procedure relates to the ability to potentially perform the INVO procedure in a physician's practice rather than in a specialized facility at a much lower cost overall than current infertility treatments. We believe that the INVO procedure will make infertility treatment more readily available throughout the world. The INVO procedure is significantly less costly than conventional in vitro fertilization ("IVF"). The INVOcell device and INVO procedure facilitates conception and embryo development inside the woman's body, rather than in a dish in a laboratory, which is an attractive feature for most couples. As of January 2019 the Company licensed the marketing and distribution rights of its products to Ferring Pharmaceuticals within the United States. This agreement provided INVO Bioscience the resources it required to each its intended markets.

Your Recent History
INVO BioSc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.